Vol 73, No 1 (2022)
Letter to the Editor
Published online: 2022-03-31
Hyperbaric oxygen therapy in necrotizing soft tissue infections caused by Vibrio species from the Baltic Sea — three clinical cases
1
, 2
, 2
Abstract
Not available
References
- Kurpas M, Michalska M, Zakrzewski A, et al. First report of the presence of Vibrio vulnificus in the Gulf of Gdansk. Int Marit Health. 2021; 72(4): 247–251.
- Huang KC, Weng HH, Yang TY, et al. Distribution of fatal vibrio vulnificus necrotizing skin and soft-tissue infections: a systematic review and meta-analysis. Medicine (Baltimore). 2016; 95(5): e2627.
- Baker-Austin C, Trinanes JA, Taylor NGH, et al. Emerging Vibrio risk at high latitudes in response to ocean warming. Nature Climate Change. 2012; 3(1): 73–77.
- Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010; 75(4): 249–257.
- Shiroff AM, Herlitz GN, Gracias VH. Necrotizing soft tissue infections. J Intensive Care Med. 2014; 29(3): 138–144.
- Misiakos EP, Bagias G, Patapis P, et al. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014; 1: 36.
- Pelletier J, Gottlieb M, Long B, et al. Necrotizing soft tissue infections (NSTI): pearls and pitfalls for the emergency clinician. J Emerg Med. 2022 [Epub ahead of print].
- Garcia NM, Cai J. Aggressive soft tissue infections. Surg Clin North Am. 2018; 98(5): 1097–1108.
- Elnahla A, Attia AS, Toraih E, et al. Prognostic factors of mortality in sepsis and soft tissue infections: meta-analysis. Surg Infect (Larchmt). 2021; 22(9): 928–939.
- Wang J, Corson K, Mader J. Hyperbaric oxygen as adjunctive therapy in Vibrio vulnificus septicemia and cellulitis. Undersea Hyperb Med. 2004; 31(1): 179–181.
- Yagi H, Takechi Y, Hiraki S, et al. [A life saving case of Vibrio vulnificus (septic type)]. Kansenshogaku Zasshi. 2003; 77(3): 167–173.
- Aksak-Wąs BJ, Ripa A, Szakoła P, et al. Septic shock induced by vibrio vulnificus in northern poland, a case report. Infect Drug Resist. 2021; 14: 5027–5033.
- Hedetoft M, Bennett MH, Hyldegaard O. Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis. Diving Hyperb Med. 2021; 51(1): 34–43.
- Memar MY, Yekani M, Alizadeh N, et al. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019; 109: 440–447.
- Tamura T, Iida Ki, Saito M, et al. Effect of hyperbaric oxygen on Vibrio vulnificus and murine infection caused by it. Microbiol Immunol. 2012; 56(10): 673–679.
- Keck PE, Gottlieb SF, Conley J. Interaction of increased pressures of oxygen and sulfonamides on the in vitro and in vivo growth of pathogenic bacteria. Undersea Biomed Res. 1980; 7(2): 95–106.
- Gottlieb SF, Pakman LM. Effect of high oxygen tensions on the growth of selected, aerobic, gram-negative, athogenic bacteria. J Bacteriol. 1968; 95(3): 1003–1010.
- Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017; 47(1): 24–32.
- Mathieu D, Ratzenhofer-Komenda B, Kot J. Hyperbaric oxygen therapy for intensive care patients: position statement by the European Committee for Hyperbaric Medicine. Diving Hyperb Med. 2015; 45(1): 42–46.
